Association of changes in circulating cell-free plasma DNA (cfDNA) and circulating tumor cells (CTC) during treatment with clinical outcome from olaparib in castration-resistant prostate cancer (CRPC): Exploratory analyses from the TOPARP-A trial.

Joaquin Mateo; Suneil Jain; Emma Hall; Johann S de Bono

Association of changes in circulating cell-free plasma DNA (cfDNA) and circulating tumor cells (CTC) during treatment with clinical outcome from olaparib in castration-resistant prostate cancer (CRPC): Exploratory analyses from the TOPARP-A trial.

Joaquin Mateo
, Suneil Jain
, Emma Hall
, Johann S de Bono

School of Medicine, Dentistry and Biomedical Sciences

Research output: Contribution to conference › Paper › peer-review

Original language	English
Pages	141
Publication status	Published - 20 Feb 2017
Event	GU ASCO Symposium - F, Orlando, United States Duration: 09 Feb 2017 → 11 Feb 2017

Conference

Conference	GU ASCO Symposium
Abbreviated title	GU ASCO
Country/Territory	United States
City	Orlando
Period	09/02/2017 → 11/02/2017

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Cite this

Mateo, J., Jain, S., Hall, E., & de Bono, J. S. (2017). Association of changes in circulating cell-free plasma DNA (cfDNA) and circulating tumor cells (CTC) during treatment with clinical outcome from olaparib in castration-resistant prostate cancer (CRPC): Exploratory analyses from the TOPARP-A trial.. 141. Paper presented at GU ASCO Symposium, Orlando, United States.

@conference{400db754721a4b108416ff4c95c73fa1,

title = "Association of changes in circulating cell-free plasma DNA (cfDNA) and circulating tumor cells (CTC) during treatment with clinical outcome from olaparib in castration-resistant prostate cancer (CRPC): Exploratory analyses from the TOPARP-A trial.",

author = "Joaquin Mateo and Suneil Jain and Emma Hall and \{de Bono\}, \{Johann S\}",

year = "2017",

month = feb,

day = "20",

language = "English",

pages = "141",

note = "GU ASCO Symposium, GU ASCO ; Conference date: 09-02-2017 Through 11-02-2017",

}

Mateo, J, Jain, S, Hall, E & de Bono, JS 2017, 'Association of changes in circulating cell-free plasma DNA (cfDNA) and circulating tumor cells (CTC) during treatment with clinical outcome from olaparib in castration-resistant prostate cancer (CRPC): Exploratory analyses from the TOPARP-A trial.', Paper presented at GU ASCO Symposium, Orlando, United States, 09/02/2017 - 11/02/2017 pp. 141.

Association of changes in circulating cell-free plasma DNA (cfDNA) and circulating tumor cells (CTC) during treatment with clinical outcome from olaparib in castration-resistant prostate cancer (CRPC): Exploratory analyses from the TOPARP-A trial. / Mateo, Joaquin; Jain, Suneil; Hall, Emma et al.
2017. 141 Paper presented at GU ASCO Symposium, Orlando, United States.

Research output: Contribution to conference › Paper › peer-review

TY - CONF

T1 - Association of changes in circulating cell-free plasma DNA (cfDNA) and circulating tumor cells (CTC) during treatment with clinical outcome from olaparib in castration-resistant prostate cancer (CRPC): Exploratory analyses from the TOPARP-A trial.

AU - Mateo, Joaquin

AU - Jain, Suneil

AU - Hall, Emma

AU - de Bono, Johann S

PY - 2017/2/20

Y1 - 2017/2/20

M3 - Paper

SP - 141

T2 - GU ASCO Symposium

Y2 - 9 February 2017 through 11 February 2017

ER -